Chemotherapy, such as cisplatin, targeted therapies like EGFR inhibitors (e.g., cetuximab), and immunotherapy with PD-1 inhibitors (e.g., pembrolizumab) are used against advanced or metastatic CSCC [55,56,57]. This evidence concerns the gene PDCD1 and skin squamous cell carcinoma.